<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: medical faculty</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>New study suggests potential shift in burden of pneumococcal disease</title>
   	 <description>New studies revealed today by Latin American researchers and global health leaders suggest that the highest burden of deadly pneumococcal disease in Latin America may be shifting to adults as countries successfully immunize more infants with new vaccines. The experts called for increased disease monitoring and more surveillance to understand the full extent of pneumococcal disease in the Americas, including its economic impact, and to devise effective strategies to prevent it.</description>
     <link>http://medicalxpress.com/news/2013-03-potential-shift-burden-pneumococcal-disease.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 05 Mar 2013 13:00:01 EST</pubDate>
	 <guid isPermaLink="false">news281709953</guid>
	 
</item>
<item>
     <title>Importance of treatment process and outcomes varies among patients with psoriasis</title>
   	 <description>Among patients with moderate to severe psoriasis, treatment options that are most compatible with their personal and professional life appear to be most important, and treatment location appears more important than probability and magnitude of treatment outcome, according to a report in the November issue of Archives of Dermatology.</description>
     <link>http://medicalxpress.com/news/2011-11-importance-treatment-outcomes-varies-patients.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 21 Nov 2011 16:00:08 EST</pubDate>
	 <guid isPermaLink="false">news241102663</guid>
	 
</item>
<item>
     <title>Using Viagra to combat malignant melanoma</title>
   	 <description>Many tumors cause chronic inflammations, which, in their turn, suppress specific attacks against the tumor by the immune system. Scientists at the German Cancer Research Center and Medical Faculty Mannheim at Heidelberg University have now shown in mice with melanoma that sildenafil - the active ingredient in Viagra - cancels the suppression of the specific immune response. Cancerous mice treated with the drug survived more than twice as long as untreated fellow animals.</description>
     <link>http://medicalxpress.com/news/2011-11-viagra-combat-malignant-melanoma.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 08 Nov 2011 11:36:10 EST</pubDate>
	 <guid isPermaLink="false">news239974553</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/usingviagrat.jpg" width="90" height="90" />
</item>
<item>
     <title>EHEC 2011 outbreak: Scientists publish their prospective genomic characterization</title>
   	 <description>Scientists of the Medical Faculty of the University Munster and the University Hospital Munster in collaboration with scientists of the enterprise 'Life Technologies Corporation' were the first to release a draft genome sequence of a German enterohemorrhagic E. coli (EHEC) 2011 outbreak strain on June 3rd. Their in-depth genomic characterization of this outbreak was published on July 20th in the online open access journal PLoS ONE.</description>
     <link>http://medicalxpress.com/news/2011-07-ehec-outbreak-scientists-publish-prospective.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 20 Jul 2011 17:43:45 EST</pubDate>
	 <guid isPermaLink="false">news230402614</guid>
	 
</item>


</channel>
</rss>
